Zaft Tablet

About Zaft 20 mg Tablet

Zaft is a 20 mg tablet from Renata PLC. that contains the generic zafirlukast. It is a leukotriene receptor antagonist used for the ongoing management of asthma in adults and older children.

There are 4 brands of Zafirlukast listed in Bangladesh. 1 of them has a lower unit price than Zaft. The lowest listed price is Zafir 20 mg Tablet at ৳ 20.07 per unit.

What is Zaft 20 mg Tablet?

Zaft 20 mg tablet is made by Renata PLC. and contains zafirlukast, a leukotriene receptor antagonist. It is prescribed for the prevention and long-term treatment of asthma in adults and children aged five years and older. It belongs to a group of medicines that block certain substances in the body involved in airway swelling and tightening. Zaft is taken regularly, including when symptoms are absent, as part of an asthma management plan. The dose and course are decided by the doctor. This medicine does not reverse sudden breathing difficulty, so ask your doctor what to do during an asthma attack.

Uses of Zaft

Zaft is used for the prophylaxis and chronic treatment of asthma in adults and children aged five years and older. It is part of ongoing asthma management and is taken regularly, even during symptom-free periods. It is not intended to reverse bronchospasm in an acute asthma attack. The doctor will decide whether it suits your condition.

How to use Zaft

Take Zaft exactly as the doctor prescribes; the dose and course are decided by the doctor. The tablet should be taken continuously to achieve benefit, including when you feel well. Food may reduce how much of the medicine the body absorbs, so ask your doctor or pharmacist about the right timing. Do not stop or change the schedule on your own. If you miss a dose, ask your doctor or pharmacist for advice.

Side effects of Zaft

In clinical trials, headache and stomach upset such as nausea, vomiting, diarrhoea and abdominal pain were reported with zafirlukast. These are usually mild and do not require stopping therapy. Bruising, bleeding disorders including heavy periods, low platelets and a fall in certain white blood cells have been reported after marketing. Tell your doctor about any unusual bleeding or bruising. Ask your doctor or pharmacist about any reaction that worries you.

Safety and precautions

Zaft is not for everyone. It should not be given to people with a history of moderate or severe kidney problems, liver impairment or cirrhosis, or allergy to any ingredient, and it is contraindicated in children under seven years. The safety of zafirlukast in human pregnancy has not been established; it is used in pregnancy only if clearly needed, and it should not be given to nursing mothers because it passes into breast milk. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding. Ask your doctor first if you have kidney or liver disease, take warfarin, or have other health conditions.

Frequently asked questions

Is Zaft safe during pregnancy or breastfeeding?

The safety of zafirlukast in human pregnancy has not been established. It should be used in pregnancy only if clearly needed. It passes into breast milk, so it should not be given to nursing mothers. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding so they can advise you.

What is Zaft used for and what kind of medicine is it?

Zaft is a leukotriene receptor antagonist. It is used for the prevention and chronic treatment of asthma in adults and children aged five years and older. It is taken regularly as part of an asthma management plan and is not meant to relieve a sudden asthma attack.

What does the generic name zafirlukast mean?

Zafirlukast is the generic name of the active ingredient in Zaft. It belongs to the leukotriene receptor antagonist group. These medicines block leukotrienes, substances in the body that contribute to airway swelling and tightening in asthma. The doctor decides how it fits into your treatment.

Can Zaft stop a sudden asthma attack?

No. Zaft is not indicated for reversing bronchospasm in an acute asthma attack. It is taken regularly for long-term asthma control. Ask your doctor what to do and which medicine to use if you have sudden breathing difficulty. Do not rely on Zaft for quick relief.

Tablet
Generic name
Zafirlukast
Strength
20 mg
Dosage form
Tablet
Manufactured by
Renata PLC.
Price in Bangladesh

৳ 26 unit price

Price updated: 16 Nov 2026

Indications

Zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older.

Pharmacology

Zafirlukast is a selective and competitive leukotriene-receptor antagonist (LTRA) of leukotriene D4 and E4 (LTD4 and LTE4), components of slow-reacting substance of anaphylaxis (SRSA). Cysteinyl leukotriene production and receptor occupation have been correlated with the pathophysiology of asthma, including airway oedema, smooth muscle constriction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.

Dosage & Administration

Zafirlukast should be taken continuously.

Children under 7 years of age: There is no clinical experience of the use of Zafirlukast in children under 7 years of age until safety information is available.

Children over 7 years through 11 years of age: The recommended dose of Zafirlukast in this age group is 10 mg twice daily.

Adult and children aged 12 years and over: The dosage is one 20 mg tablet twice daily. This dosage should not be exceeded. Higher doses may be associated with elevations of one or more liver enzymes consistent with hepatotoxicity. As food may reduce the bioavailability of Zafirlukast, Zafirlukast should not be taken with meals

Elderly: The clearance of Zafirlukast is significantly reduced in elderly patients (over 65 years old), and Cmax and AUC are approximately double than those of younger adults. However, accumulation of Zafirlukast is not greater than that seen in multiple dose trials conducted in adult subjects with asthma and the consequences of the altered kinetic in the elderly are unknown. Clinical experience with Zafirlukast in the elderly (over 65 years) is limited and caution is recommended until further information is available.

Renal impairment: No dosage adjustment is necessary in patients with mild renal impairment.

Interaction

Zafirlukast may be administered with other therapies routinely used in the management of asthma and allergy. Inhaled steroids, inhaled and oral bronchodilator therapy, antibiotics and antihistamines are examples of agents which have been co-administered with Zafirlukast without adverse interaction.

Zafirlukast may be administered with oral contraceptives without adverse interaction. Co-administration with Warfarin results in an increase in maximum prothrombin time by approximately 35%. It is therefore recommended that if Zafirlukast is co-administered with Warfarin, prothrombin time should be closely monitored. The interaction is probably due to an inhibition by Zafirlukast of the cytochrome P450 2C9 enzyme system. In clinical trials co-administration with Theophylline resulted in decreased plasma levels of Zafirlukast, by approximately 30%, but with no effect on plasma Theophylline levels. However, during postmarketing surveillance, there have been rare cases of patients experiencing increased Theophylline levels when co-administered with Zafirlukast.

Co-administration with Terfenadine resulted in a 54% decrease in AUC for Zafirlukast, but with no effect on plasma Terfenadine levels. Coadministration with Acetylsalicylic acid (650 mg four times a day) may result in increased plasma levels of Zafirlukast, by approximately 45%.

Co-administration with Erythromycin will result in decreased plasma levels of Zafirlukast, by approximately 40%. The clearance of Zafirlukast in smokers may be increased by approximately 20%

Contraindications

Zafirlukast should not be given to patients who have previously experienced hypersensitivity to the product or any of its ingredients. Zafirlukast is contraindicated in patients with a history of moderate or severe renal impairment. Zafirlukast is contraindicated in patients with hepatic impairment or cirrhosis; it has not been studied in patients with hepatitis or in long term studies of patients with cirrhosis. Zafirlukast is contraindicated in children under 7 years of age until safety information is available.

Side Effects

Effect on ability to drive or operate machinery: There is no evidence that Zafirlukast affects the ability to drive and use machinery. Administration of Zafirlukast in clinical trials against placebo has been associated with headache (9.9% vs. 9.0%) or gastrointestinal disturbance (nausea 2.6% vs. 2.2%, vomiting 1.2% vs. 1.0%, diarrhoea 2.3% vs. 1.8%, abdominal pain 1.6% vs. 1.2%). These symptoms are usually mild and do not necessitate withdrawal from therapy. During post-marketing experience, bruising, bleeding disorders, including menorrhagia (rare), thrombocytopaenia and agranulocytosis (very rare) have also been reported.

Hypersensitivity reactions, including urticaria and angio-oedema have been reported. Rashes, including blistering, have also been reported. The above events have usually resolved during continued treatment or following cessation of therapy.

Infrequently, elevated serum transaminase levels have been observed in clinical trials against placebo with Zafirlukast (increased AST 1.0% vs. 0.9%, increased AST 0.6% vs. 0.6%); at recommended doses the incidence was equivalent to placebo. Rarely the transaminase profile has been consistent with drug-induced hepatitis, which resolved following cessation of Zafirlukast therapy. During post-marketing experience there have been rare reports of hepatitis, with or without elevated bilirubin levels. These cases were usually reversible.

In placebo controlled clinical trials, an increased incidence of infection has been observed in elderly patients given Zafirlukast (7.8% vs. 1.4%). Infections were usually mild, predominantly affecting the respiratory tract.

Pregnancy & Lactation

Pregnancy: The safety of Zafirlukast in human pregnancy has not been established. In animal studies, Zafirlukast did not have any apparent effect on fertility and did not appear to have any teratogenic or selective toxic effect on the foetus. The potential risks should be weighed against the benefits of continuing therapy during pregnancy and Zafirlukast should be used during pregnancy only if clearly needed.

Lactation
: Zafirlukast is excreted in human breast milk. Zafirlukast should not be administered to nursing mothers.

Precautions & Warnings

Zafirlukast should be taken regularly to achieve benefit, even during symptom free periods. Zafirlukast therapy should normally be continued during acute exacerbations of asthma. Zafirlukast does not allow a reduction in existing steroid treatment. As with inhaled steroids and hormones (disodium cromoglycate, nedocromil sodium), Zafirlukast is not indicated for use in the reversal of bronchospasm in acute asthma attacks. Zafirlukast has not been evaluated in the treatment of labile (brittle) or unstable asthma.

Cases of Churg Strauss syndrome have been reported in association with Zafirlukast usage. A causal relationship has neither been confirmed nor refuted. If a patient develops a Churg Strauss syndrome type illness, Zafirlukast should be stopped, a re-challenge test should not be performed and treatment should not be restarted.

Elevations in serum transaminases can occur during treatment with Zafirlukast. These are usually asymptomatic and transient but could represent early evidence of hepatotoxicity.

If clinical symptoms or signs suggestive of liver dysfunction occur (e.g., nausea, vomiting, right upper quadrant pain, fatigue, lethargy, flu-like symptoms, enlarged liver, pruritus and jaundice), the serum transaminases, in particular serum ALT, should be measured and the patient managed accordingly. A decision to discontinue Zafirlukast should be individualized to the patient’s condition, weighing the risk of hepatic dysfunction against the clinical benefit of Zafirlukast to the patient.

Storage Conditions

Store between 20-25° C. Protect from light and moisture.

Alternative brands of Zafirlukast

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.